Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohn's disease trial - Bekker, P; Petryka, R; Vanasek, T; Niv, Y; Marlicz, K; Haagen-Nielsen, O; Dahelrup, J; Dotan, I; Compel, V; Keshav, S; Schall, T (2008)